Matches in SemOpenAlex for { <https://semopenalex.org/work/W2972432841> ?p ?o ?g. }
- W2972432841 endingPage "E1024" @default.
- W2972432841 startingPage "E1018" @default.
- W2972432841 abstract "<h3>BACKGROUND:</h3> Donepezil, rivastigmine and galantamine are popular cholinesterase inhibitors used to manage the symptoms of Alzheimer disease and other dementias; regulatory agencies in several countries warn about a possible risk of rhabdomyolysis with donepezil, based on information from case reports. Our goal was to investigate the 30-day risk of admission to hospital with rhabdomyolysis associated with initiating donepezil versus other cholinesterase inhibitors. <h3>METHODS:</h3> We conducted a retrospective cohort study in Ontario, Canada, from 2002 to 2017. Participants were adults aged 66 years or older with a newly dispensed prescription for donepezil compared with rivastigmine or galantamine. The primary outcome was hospital admission with rhabdomyolysis (assessed using hospital diagnostic codes) within 30 days of a new prescription of a cholinesterase inhibitor. Odds ratios were estimated using logistic regression, with inverse probability of treatment weights calculated from propensity scores. <h3>RESULTS:</h3> The average age in our 2 groups was 81.1 years, and 61.4% of our population was female. Donepezil was associated with a higher risk of hospital admission with rhabdomyolysis compared with rivastigmine or galantamine (88 events in 152 300 patients [0.06%] v. 16 events in 68 053 patients [0.02%]; weighted odds ratio of 2.21, 95% confidence interval [CI] 1.52–3.22). Most hospital admissions with rhabdomyolysis after donepezil use were not severe, and no patient was treated with acute dialysis or mechanical ventilation. <h3>INTERPRETATION:</h3> Initiating donepezil is associated with a higher 30-day risk of admission to hospital with rhabdomyolysis compared with initiating rivastigmine or galantamine. The proportion of patients who develop severe rhabdomyolysis within 30 days of initiating donepezil is very low." @default.
- W2972432841 created "2019-09-19" @default.
- W2972432841 creator A5000432740 @default.
- W2972432841 creator A5001731019 @default.
- W2972432841 creator A5022265533 @default.
- W2972432841 creator A5030762655 @default.
- W2972432841 creator A5056628587 @default.
- W2972432841 creator A5063180254 @default.
- W2972432841 date "2019-09-15" @default.
- W2972432841 modified "2023-10-16" @default.
- W2972432841 title "Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study" @default.
- W2972432841 cites W100013426 @default.
- W2972432841 cites W101190257 @default.
- W2972432841 cites W1895538680 @default.
- W2972432841 cites W1904458203 @default.
- W2972432841 cites W1973078413 @default.
- W2972432841 cites W2008266999 @default.
- W2972432841 cites W2035380893 @default.
- W2972432841 cites W2045562525 @default.
- W2972432841 cites W2049540822 @default.
- W2972432841 cites W2057679568 @default.
- W2972432841 cites W2059078444 @default.
- W2972432841 cites W2070350490 @default.
- W2972432841 cites W2075006590 @default.
- W2972432841 cites W2085907924 @default.
- W2972432841 cites W2102282157 @default.
- W2972432841 cites W2108829860 @default.
- W2972432841 cites W2116325340 @default.
- W2972432841 cites W2163278718 @default.
- W2972432841 cites W2192171349 @default.
- W2972432841 cites W2298316823 @default.
- W2972432841 cites W2580510825 @default.
- W2972432841 cites W2767891136 @default.
- W2972432841 cites W2785156354 @default.
- W2972432841 cites W2789639648 @default.
- W2972432841 cites W4243726058 @default.
- W2972432841 cites W4285719527 @default.
- W2972432841 doi "https://doi.org/10.1503/cmaj.190337" @default.
- W2972432841 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6751039" @default.
- W2972432841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31527187" @default.
- W2972432841 hasPublicationYear "2019" @default.
- W2972432841 type Work @default.
- W2972432841 sameAs 2972432841 @default.
- W2972432841 citedByCount "9" @default.
- W2972432841 countsByYear W29724328412019 @default.
- W2972432841 countsByYear W29724328412020 @default.
- W2972432841 countsByYear W29724328412021 @default.
- W2972432841 countsByYear W29724328412022 @default.
- W2972432841 crossrefType "journal-article" @default.
- W2972432841 hasAuthorship W2972432841A5000432740 @default.
- W2972432841 hasAuthorship W2972432841A5001731019 @default.
- W2972432841 hasAuthorship W2972432841A5022265533 @default.
- W2972432841 hasAuthorship W2972432841A5030762655 @default.
- W2972432841 hasAuthorship W2972432841A5056628587 @default.
- W2972432841 hasAuthorship W2972432841A5063180254 @default.
- W2972432841 hasBestOaLocation W29724328411 @default.
- W2972432841 hasConcept C126322002 @default.
- W2972432841 hasConcept C156957248 @default.
- W2972432841 hasConcept C167135981 @default.
- W2972432841 hasConcept C201903717 @default.
- W2972432841 hasConcept C2776332859 @default.
- W2972432841 hasConcept C2779056891 @default.
- W2972432841 hasConcept C2779134260 @default.
- W2972432841 hasConcept C2779379848 @default.
- W2972432841 hasConcept C2779483572 @default.
- W2972432841 hasConcept C2780904820 @default.
- W2972432841 hasConcept C2908647359 @default.
- W2972432841 hasConcept C42219234 @default.
- W2972432841 hasConcept C71924100 @default.
- W2972432841 hasConcept C72563966 @default.
- W2972432841 hasConcept C99454951 @default.
- W2972432841 hasConceptScore W2972432841C126322002 @default.
- W2972432841 hasConceptScore W2972432841C156957248 @default.
- W2972432841 hasConceptScore W2972432841C167135981 @default.
- W2972432841 hasConceptScore W2972432841C201903717 @default.
- W2972432841 hasConceptScore W2972432841C2776332859 @default.
- W2972432841 hasConceptScore W2972432841C2779056891 @default.
- W2972432841 hasConceptScore W2972432841C2779134260 @default.
- W2972432841 hasConceptScore W2972432841C2779379848 @default.
- W2972432841 hasConceptScore W2972432841C2779483572 @default.
- W2972432841 hasConceptScore W2972432841C2780904820 @default.
- W2972432841 hasConceptScore W2972432841C2908647359 @default.
- W2972432841 hasConceptScore W2972432841C42219234 @default.
- W2972432841 hasConceptScore W2972432841C71924100 @default.
- W2972432841 hasConceptScore W2972432841C72563966 @default.
- W2972432841 hasConceptScore W2972432841C99454951 @default.
- W2972432841 hasIssue "37" @default.
- W2972432841 hasLocation W29724328411 @default.
- W2972432841 hasLocation W29724328412 @default.
- W2972432841 hasLocation W29724328413 @default.
- W2972432841 hasLocation W29724328414 @default.
- W2972432841 hasOpenAccess W2972432841 @default.
- W2972432841 hasPrimaryLocation W29724328411 @default.
- W2972432841 hasRelatedWork W1979069737 @default.
- W2972432841 hasRelatedWork W2033929773 @default.
- W2972432841 hasRelatedWork W2049472582 @default.
- W2972432841 hasRelatedWork W2124088010 @default.
- W2972432841 hasRelatedWork W2748604790 @default.